Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hadváry

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|October 25, 1991
Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitorsD W Banner, P Hadváry
Thrombosis Research|April 15, 1983
Activation of human and rabbit blood platelets by synthetic structural analogs of platelet activating factorP Hadváry, H R Baumgartner
The Biochemical Journal|December 1, 1988
Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatinP Hadváry, H Lengsfeld, H Wolfer
FEBS Letters|March 24, 1992
Identification of the active-site serine in human pancreatic lipase by chemical modification with tetrahydrolipstatinQ Lüthi-Peng, H P Märki, P Hadváry
The Journal of Clinical Investigation|May 1, 1994
Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitorsD Kirchhofer, T B Tschopp, P Hadváry, et al.
The Journal of Biological Chemistry|August 5, 1989
Ca2+-dependent binding of a synthetic Arg-Gly-Asp (RGD) peptide to a single site on the purified platelet glycoprotein IIb-IIIa complexB Steiner, D Cousot, A Trzeciak, et al.
The Journal of Biological Chemistry|February 5, 1991
The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipaseP Hadváry, W Sidler, W Meister, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1993
Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dogS P Roux, T B Tschopp, H Kuhn, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 1, 1993
Ro 44-9883, a new nonpeptide glycoprotein IIb/IIIa antagonist, prevents platelet loss during experimental cardiopulmonary bypassJ P Carteaux, S Roux, H Kuhn, et al.
Thrombosis Research|December 1, 1993
Tetrafibricin: a nonpeptidic fibrinogen receptor inhibitor from Streptomyces neyagawaensis (I). Its GPIIb/IIIa blockage on solid phase binding assayT Satoh, Y Yamashita, T Kamiyama, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|October 25, 1991
Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitorsD W Banner, P Hadváry
Thrombosis Research|April 15, 1983
Activation of human and rabbit blood platelets by synthetic structural analogs of platelet activating factorP Hadváry, H R Baumgartner
The Biochemical Journal|December 1, 1988
Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatinP Hadváry, H Lengsfeld, H Wolfer
FEBS Letters|March 24, 1992
Identification of the active-site serine in human pancreatic lipase by chemical modification with tetrahydrolipstatinQ Lüthi-Peng, H P Märki, P Hadváry
The Journal of Clinical Investigation|May 1, 1994
Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitorsD Kirchhofer, T B Tschopp, P Hadváry, et al.
The Journal of Biological Chemistry|August 5, 1989
Ca2+-dependent binding of a synthetic Arg-Gly-Asp (RGD) peptide to a single site on the purified platelet glycoprotein IIb-IIIa complexB Steiner, D Cousot, A Trzeciak, et al.
The Journal of Biological Chemistry|February 5, 1991
The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipaseP Hadváry, W Sidler, W Meister, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1993
Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dogS P Roux, T B Tschopp, H Kuhn, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 1, 1993
Ro 44-9883, a new nonpeptide glycoprotein IIb/IIIa antagonist, prevents platelet loss during experimental cardiopulmonary bypassJ P Carteaux, S Roux, H Kuhn, et al.
Thrombosis Research|December 1, 1993
Tetrafibricin: a nonpeptidic fibrinogen receptor inhibitor from Streptomyces neyagawaensis (I). Its GPIIb/IIIa blockage on solid phase binding assayT Satoh, Y Yamashita, T Kamiyama, et al.
Pageof 2